Skip to main content
Log in

Evaluation of Cardiotoxicity by Tissue Doppler Imaging in Childhood Leukemia Survivors Treated with Low-Dose Anthracycline

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Improvement in long-term survival in patients with acute childhood leukemia has led to the need for monitorization of chemotherapy-related morbidity and mortality. This study included 60 patients with acute lymphoblastic leukemia that were in remission for at least 2 years and 30 healthy controls. Systolic and diastolic function of myocardium was evaluated using conventional echocardiography and tissue Doppler imaging of the left ventricle, interventricular septum and right ventricle. Median age of patients was 11.7 years (range 10–14.9 years), and the median duration of remission was 4 years (range 2.5–5 years). All patients were treated with a low cumulative dose of adriamycin (100 mg/m2) according to the St. Jude Total-XIIIA protocol. The ejection fraction (EF) and fractional shortening were normal in the patient and control groups, even though EF values were significantly lower in the patients (69.5 ± 2.3 vs. 72.7 ± 3 %, P < 0.01). Myocardial systole (S m), early diastole (E m) and late diastole (A m) velocities in all segments of the myocardium were significantly lower in the patient group (P < 0.01 for all segments). Cardiotoxicity was noted in all segments of the myocardium in the patient group, despite the fact that they were all treated with a low cumulative dose of adriamycin. Based on these findings, we think that there is no safe dose for anthracyclines and periodic echocardiographic evaluation of both the left and right ventricles must be performed in all patients treated with anthracyclines, even at low doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. ACC/AHA/ASE (2003) Guideline update for the clinical application of echocardiography: a report of the ACC/AHA/ASE Committee to update the 1997 guidelines. Circulation 2003(108):1146–1162

    Google Scholar 

  2. Adams MJ, Lipshultz SE (2005) Pathophysiology of anthracycline and radiation associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer 44:600–606

    Article  PubMed  Google Scholar 

  3. Alehan D, Sahin M, Varan A, Yıldırım I, Küpeli S, Büyükpamukçu M (2012) Tissue Doppler evaluation of systolic and diastolic cardiac functions in long term survivors of Hodgkin lymphoma. Pediatr Blood Cancer 58:250–255

    Article  PubMed  Google Scholar 

  4. Ayhan SS, Özdemir K, Kayrak M, Bacaksiz A, Vatankulu MA, Eren Ö et al (2012) The evaluation of doxorubicin-induced cardiotoxicity: comparison of Doppler and tissue Doppler-derived myocardial performance index. Cardiol J 19:363–368

    Article  PubMed  Google Scholar 

  5. Baysal T, Koksal Y, Oran B, Sen M, Unal E, Cimen D (2010) Cardiac functions evaluated with tissue Doppler imaging in childhood cancers treated with anthracyclines. Pediatr Hematol Oncol 27:13–23

    Article  CAS  PubMed  Google Scholar 

  6. Dragulescu A, Mertens LL (2010) Developments in echocardiographic techniques for the evaluation of ventricular function in children. Arch Cardiovasc Dis 103:603–614

    Article  PubMed  Google Scholar 

  7. Eidem BW, Sapp BG, Suarez CR, Cetta F (2001) Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. Am J Cardiol 87:1120–1122

    Article  CAS  PubMed  Google Scholar 

  8. Galderisi M, Cattaneo F, Mondillo S (2007) Doppler echocardiography and myocardial dyssynchrony: a practical update of old and new ultrasound technologies. Cardiovascular Ultrasound 5:28–41

    Article  PubMed Central  PubMed  Google Scholar 

  9. Ganame J, Claus P, Uyttebroeck A, Renard M, D’hooge J, Bijnens B et al (2007) Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. J Am Soc Echocardiogr 20:1351–1358

    Article  PubMed  Google Scholar 

  10. Garcia-Fernandez MA, Zamorano J, Azevedo J (eds) (1998) Doppler Tissue imaging. McGraw-Hill, Madrid

    Google Scholar 

  11. Guidelines and standards for performance of a pediatric echocardiogram (2006) A report from the task force of the pediatric council of the American Society of Echocardiography. J Am Soc Echocardiogr 19:1413–1430

    Article  Google Scholar 

  12. Haddy TB, Mosher RB, Reaman GH (2009) Late effects in long-term survivors after treatment for childhood acute leukemia. Clin Pediatr 48:601–608

    Article  Google Scholar 

  13. Karakurt C, Koçak G, Ozgen U (2008) Evaluation of the left ventricular function with tissue tracking and tissue Doppler echocardiography in pediatric malignancy survivors after anthracycline therapy. Echocardiography 25:880–887

    Article  PubMed  Google Scholar 

  14. Kocabaş A, Kardelen F, Ertuğ H, Aldemir-Kocabaş B, Tosun Ö, Yeşilipek A et al (2014) Assessment of early-onset chronic progressive anthracycline cardiotoxicity in children: different response patterns of right and left ventricles. Pediatr Cardiol 35(1):82–88

    Article  PubMed  Google Scholar 

  15. Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD (2005) Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2236–2629

    Google Scholar 

  16. Lipshultz SE, Alvarez JA, Scully RE (2008) Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 94:525–533

    Article  CAS  PubMed  Google Scholar 

  17. Ness KK, Armenian SH, Kadan-Lottick N, Gurney JG (2011) Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert Rev Hematol 4:185–197

    Article  PubMed Central  PubMed  Google Scholar 

  18. Nikitin NP, Witte KK (2004) Application of tissue Doppler imaging in cardiology. Cardiology 101:170–184

    Article  PubMed  Google Scholar 

  19. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582

    Article  CAS  PubMed  Google Scholar 

  20. Pui CH, Boyett JM, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC et al (2000) Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children’s Research Hospital. Leukemia 14:2286–2294

    Article  CAS  PubMed  Google Scholar 

  21. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC et al (2009) Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730–2741

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Rathe M, Carlsen NL, Oxhøj H (2007) Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 48:663–667

    Article  PubMed  Google Scholar 

  23. Rathe M, Carlsen NL, Oxhøj H, Nielsen G (2010) Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2 or less for acute lymphoblastic leukemia. Pediatr Blood Cancer 54:444–448

    Article  PubMed  Google Scholar 

  24. Shankar SM, Marina N, Hudson MM, Hodgson DC, Adams MJ, Landier W et al (2008) Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the Cardiovascular Disease Task Force of the Children’s Oncology Group. Pediatrics 121:e387–e396

    Article  PubMed  Google Scholar 

  25. Temming P, Qureshi A, Hardt J, Leiper AD, Levitt G, Ancliff PJ, Webb DK (2011) Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom. Pediatr Blood Cancer 56:625–630

    Article  PubMed  Google Scholar 

  26. Trachtenberg BH, Landy DC, Franco VI, Henkel JM, Pearson EJ, Miller TL, Lipshultz SE (2011) Anthracycline associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol 32:342–353

    Article  PubMed  Google Scholar 

  27. Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B (2012) Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood. J Cancer Surviv 6:95–101

    Article  PubMed Central  PubMed  Google Scholar 

  28. Yeh ET, Bickford CL (2009) Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53:2231–2247

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cengiz Bayram.

Additional information

Cengiz Bayram and İlker Çetin have contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bayram, C., Çetin, İ., Tavil, B. et al. Evaluation of Cardiotoxicity by Tissue Doppler Imaging in Childhood Leukemia Survivors Treated with Low-Dose Anthracycline. Pediatr Cardiol 36, 862–866 (2015). https://doi.org/10.1007/s00246-015-1096-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-015-1096-6

Keywords

Navigation